Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Proof-of-Principle Demonstration of Direct Metabolic Imaging Following Myocardial Infarction Using Hyperpolarized 13C CMR.

Journal article

Apps A. et al, (2021), JACC Cardiovasc Imaging, 14, 1285 - 1288

BH4 Increases nNOS Activity and Preserves Left Ventricular Function in Diabetes.

Journal article

Carnicer R. et al, (2021), Circ Res, 128, 585 - 601

A 3D hybrid-shot spiral sequence for hyperpolarized 13 C imaging.

Journal article

Tyler A. et al, (2021), Magn Reson Med, 85, 790 - 801

Hyperpolarized MR in cardiology: probing the heart of life

Chapter

Miller JJ. et al, (2021), Advances in Magnetic Resonance Technology and Applications, 217 - 256

Nicotinic acid receptor agonists impair myocardial contractility by energy starvation.

Journal article

Watson WD. et al, (2020), FASEB J, 34, 14878 - 14891

Effects of contrast agents on relaxation properties of 31P metabolites.

Journal article

Valkovič L. et al, (2020), Magn Reson Med

A 3D hybrid-shot spiral sequence for hyperpolarized 13C imaging

Journal article

TYLER D. et al, (2020), Magnetic Resonance in Medicine

Hyperpolarized 13C MRI: A novel approach for probing cerebral metabolism in health and neurological disease.

Journal article

Grist JT. et al, (2020), J Cereb Blood Flow Metab, 40, 1137 - 1147

Use of cardiac magnetic resonance to detect changes in metabolism in heart failure.

Journal article

Watson WD. et al, (2020), Cardiovasc Diagn Ther, 10, 583 - 597

CARDIAC METABOLIC MANIPULATION ALTERS CARDIAC ENERGETICS AND FUNCTION

Conference paper

Watson W. et al, (2020), CARDIOVASCULAR DRUGS AND THERAPY, 34, 281 - 281

PHARMACOLOGICALLY TARGETING HIF1A TO IMPROVE POST-ISCHEMIC FUNCTION OF THE TYPE 2 DIABETIC HEART

Conference paper

Fialho MDLS. et al, (2020), CARDIOVASCULAR DRUGS AND THERAPY, 34, 273 - 273

Load More